Clinical trials
Squamous Intraepithelial Lesions trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 5 |
| 2025 | 3 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 11 |
| Recruiting | 6 |
| Not yet recruiting | 4 |
| Completed | 3 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fujian Maternity and Child Health Hospital | 5 |
| Lei Li | 4 |
| Newish Biotech (Wuxi) Co., Ltd. | 3 |
| Peking University People's Hospital | 2 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 2 |
| First Affiliated Hospital of Wenzhou Medical University | 1 |
| Newish Technology (Beijing) Co., Ltd. | 1 |
| Obstetrics & Gynecology Hospital of Fudan University | 1 |
| Shandong University | 1 |
| Shanghai BDgene Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Squamous Intraepithelial Lesions | 26 |
| Papillomavirus Infections | 11 |
| Uterine Cervical Dysplasia | 8 |
| Uterine Cervical Neoplasms | 7 |
| Adenocarcinoma in Situ | 3 |
| Atypical Squamous Cells of the Cervix | 2 |
| Bowen's Disease | 1 |
| Margins of Excision | 1 |
| Neoplasms | 1 |
| Recurrence | 1 |
Trials
Showing 26 to 26 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.